New deal in dry eye innovation

Professor Ben Thompson

The Centre for Eye and Vision Research (CEVR) and Scope Health have announced a new collaborative partnership focused on developing innovative technologies for dry eye disease and other ocular surface conditions.

Professor Ben Thompson, CEO and scientific director of CEVR, remarked: “We are thrilled to collaborate with Scope Health, a leading innovator in management solutions for ocular surface diseases. Through this collaboration and Scope’s ardent support, engagement in areas such as dry eye management at the practice level and global outreach will increase substantially to deliver tangible change.

Tom Freyne

“The research results will advance CEVR’s mission to develop technologies that preserve and enhance vision worldwide. This partnership merges cutting-edge science with formulation and commercialisation expertise, paving the way for a transformative solution to support developing technologies that preserve and enhance healthy vision worldwide.”

Tom Freyne, CEO of Scope Health, said: “Disrupting the status quo and establishing a new standard of care for ocular surface diseases requires collective efforts. Under the leadership of CEVR’s principal investigators, Professor Lyndon Jones and Dr Chau-Minh Phan, along with Dr Howard Ketelson, head of ideation and discovery at Scope, this collaboration collectively harnesses our expertise’s to develop and commercialise differentiated and clinically valued eyecare products.”

CEVR is a research collaboration between the Hong Kong Polytechnic University and the University of Waterloo in Canada under the InnoHK initiative of the HKSAR government.